跳至主要内容
临床试验/CTRI/2021/02/031600
CTRI/2021/02/031600尚未招募2 期

Efficacy and Safety of Zinc in the Prevention of Oral Mucositis in Children with Cancer receiving intensified Chemotherapy: A Randomized Double-Blind Placebo-Controlled Trial

All India Institute Of Medical Sciences New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients of 3-18 years of age with cancer receiving intensified chemotherapy
  • 2.Informed consent
  • 3.No any oral lesion at the time of enrollment

排除标准

  • 1.Patient receiving intensified chemotherapy over a period of more than five days
  • 2.If child received systematic zinc within last 14 days for any indication for a period of more than 5 days.
  • 3.Any contra-indications to the use of oral zinc:
  • 3.1 Any documented allergic reaction/hypersensitivity to oral zinc
  • 3.2 Any patient who is vomiting excessively due to any cause.

研究者

发起方
All India Institute Of Medical Sciences New Delhi

相似试验